Canopy Growth Delivers 68% YoY International Cannabis Revenue Growth In Q4

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) reported on Monday a 10% year-over-year increase in consolidated net revenue to CA$71.2 million ($50.9 million) in the fourth quarter of fiscal 2026, while full-year revenue grew 6% to CA$284.6 million over the same period.

Cannabis net revenue rose 20% year-over-year for the fourth quarter and 15% for the fiscal year 2026. Adjusted EBITDA loss improved to CA$6.3 million in the fourth quarter and narrowed 14% year-over-year to CA$20.2 million for the full fiscal year.

Canadian cannabis giant showed operational discipline as in fiscal 2026, selling, general and administrative expenses decreased 6% year-over-year, reflecting cost reductions and efficiency initiatives.

CEO Luc Mongeau called fiscal 2026 a year of restructuring, strategic investment, and building a foundation for growth, highlighting the medical cannabis business segment and the European market.

“As the leading medical cannabis business in Canada by revenue, we are well positioned to extend that leadership into Europe – a market we believe represents enormous long-term opportunity and one where our brands, products and relentless execution give us a real competitive edge,” Mongeau said in a press release.

In fiscal 2027, the company’s management expects revenue growth, improved margins, lower operating expenses, and positive adjusted EBITDA.

“We enter fiscal 2027 with momentum, clarity, and a team that has proven it can execute,” Mongeau continued.

Q4 And FY2026 Financial Highlights

• Canadian medical cannabis revenue totaled CA$25.3 million in the fourth quarter, up 27% year-over-year.
• Canada’s adult-use cannabis net revenue was CA$20.6 million, up 1% year-over-year.
• International cannabis markets amounted to CA$8.6 million in the fourth quarter, representing a 68% year-over-year increase.
• Fourth quarter net loss from continuing operations was 21% lower year-over-year.
• Consolidated gross margin in the fourth quarter was 12%, compared to 16% in the prior year’s period.
• Free cash outflow improved year-over-year, from CA$176.6 million to CA$69.1 million in fiscal 2026.
• Net cash position of CA$131.3 million at the end of fiscal 2026, representing an improvement of CA$303.9 million compared to net debt of CA$172.6 million at the end of fiscal 2025.

CGC Price Action

Canopy’s shares traded 0.57% lower at CA$0.9943 per share at the time of writing on Monday morning.